Chylothorax (Chylous Pleural Effusion)

Accumulation of lymphatic fluid (chyle, rich in triglycerides and chylomicrons) in the pleural space due to thoracic duct disruption, typically appearing milky white with pleural fluid triglycerides >110 mg/dL or presence of chylomicrons.

Written by: Saygı Hospital Health Guide Editorial Board

Last updated: June 13, 2026

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Göğüs Hastalıkları department. Book Appointment →

What is Chylothorax (Chylous Pleural Effusion)?

Chylothorax is the accumulation of chyle (intestinal lymph rich in triglyceride-laden chylomicrons) in the pleural space due to disruption of the thoracic duct or its tributaries. The thoracic duct ascends in the right posterior mediastinum and crosses to the left at the T4–T5 level; injury below the crossover causes right chylothorax, above causes left chylothorax. Etiology is divided into traumatic (50%, postoperative cardiothoracic and esophageal surgery, central venous catheterization, trauma) and nontraumatic (50%, malignancy especially lymphoma, lymphangioleiomyomatosis, tuberculosis, congenital).

Diagnosis: pleural fluid is typically milky-white but may be serous, especially in fasting state. Diagnostic criteria are pleural fluid triglycerides >110 mg/dL (high probability), 50–110 mg/dL (probable, requires lipoprotein electrophoresis), or presence of chylomicrons by lipoprotein electrophoresis (definitive). Cholesterol/triglyceride ratio <1 supports chylothorax over pseudochylothorax (chronic effusion with cholesterol crystals). CT chest evaluates underlying cause; lymphangiography (conventional or MR) localizes leak.

Management is etiology-specific. Conservative approach: nil per os (NPO) with total parenteral nutrition or low-fat diet with medium-chain triglycerides (absorbed directly into portal system, bypassing lymphatics), pleural drainage with chest tube, somatostatin or octreotide (reduces chyle flow). Treat underlying malignancy (chemotherapy/radiation for lymphoma). High-output (>1,000 mL/day for >5 days) or persistent (>2 weeks) chylothorax warrants intervention: thoracic duct ligation (surgical via VATS or thoracotomy), thoracic duct embolization (interventional radiology), pleuroperitoneal shunt, or pleurodesis. Octreotide is also helpful in pediatric and post-cardiac surgery chylothorax.

Symptoms

Dyspnea progressive with effusion accumulation

Chest discomfort or pleuritic pain

Cough, decreased breath sounds on affected side

Postoperative or post-traumatic pleural effusion

Milky-white pleural fluid on thoracentesis

Weight loss, malnutrition (chronic chyle loss)

Lymphopenia, immunosuppression with chronic loss

Risk Factors

Cardiothoracic surgery (CABG, valve, lung resection, esophagectomy)

Trauma (penetrating, blunt cervicothoracic injury)

Central venous catheterization (subclavian, internal jugular)

Lymphoma (Hodgkin, non-Hodgkin) — most common nontraumatic

Lymphangioleiomyomatosis (LAM)

Tuberculosis with mediastinal lymphadenopathy

Congenital lymphatic anomalies (kaposiform lymphangiomatosis)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

Postoperative pleural effusion or new pleural fluid
Milky-white pleural drainage
Persistent dyspnea after thoracic surgery
Unexplained pleural effusion with weight loss
Increasing chest tube output postoperatively
Effusion with mediastinal mass (suspect lymphoma)
Recurrent pleural effusion of unclear etiology

Treatment Methods

Conservative: NPO with TPN or low-fat MCT diet, chest tube drainage

Octreotide (somatostatin analog) to reduce chyle flow

Treat underlying malignancy (chemotherapy/radiation for lymphoma)

Thoracic duct ligation (VATS or thoracotomy) for high-output or refractory cases

Thoracic duct embolization (interventional radiology) as alternative

Pleurodesis (talc, doxycycline) or pleuroperitoneal shunt if surgery contraindicated

Nutritional support and immunoglobulin replacement for chronic loss

Which Department to Visit?

You can visit our Göğüs Hastalıkları department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Göğüs Hastalıkları Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book Appointment Contact Us

Related Health Topics

Other articles from the same department you may want to explore.

Chylothorax (Thoracic Duct Leak)

Göğüs Hastalıkları

Chylothorax is the accumulation of chyle (a lymphatic fluid rich in fat absorbed from intestines) in the pleural space, occurring when the thoracic duct or its lymphatic tributaries are disrupted, blocked, or rupture, causing leakage into pleural cavity. Etiology categories: (1) Traumatic (50-60%): post-surgical (most common modern cause; especially esophagectomy 1-3%, lung resection 0.5-2%, cardiac surgery, neck dissection, mediastinal procedures), penetrating chest trauma, blunt thoracic trauma. (2) Non-traumatic (40-50%): malignancy (most commonly lymphoma 30-40%, then lung cancer, metastases obstructing thoracic duct), congenital lymphatic anomalies (lymphangioleiomyomatosis LAM, congenital pulmonary lymphangiectasia, Noonan syndrome, Down syndrome), hepatic cirrhosis with hepatic hydrothorax (rare), tuberculosis, sarcoidosis, retrosternal goiter, and idiopathic (10%). Clinical presentation: dyspnea, cough, chest pressure, chest fullness from large pleural effusion. Diagnosis based on milky-white appearance of pleural fluid (although clear in fasting state if patient is not eating), and CONFIRMED by pleural fluid analysis showing triglycerides over 110 mg/dL (over 1.24 mmol/L; values 50-110 with chylomicrons present is diagnostic), presence of chylomicrons by lipoprotein electrophoresis (most specific), cholesterol typically less than 200 mg/dL (helps distinguish from pseudochylothorax which has cholesterol over 200), and lymphocyte predominant cell count. Imaging: chest CT for malignancy and lymph node assessment, lymphangiography or magnetic resonance lymphangiography (MRL) to localize leak site. Treatment: conservative management is first-line (50-80% success): low-fat diet with medium-chain triglycerides (MCT) bypassing thoracic duct, NPO with total parenteral nutrition (TPN) if conservative fails, somatostatin analog octreotide 50-100 micrograms SC three times daily reduces chyle production, and pleurodesis. Surgical thoracic duct ligation (open or thoracoscopic) for refractory chylothorax over 2-4 weeks of conservative therapy or output more than 1500 mL/day. Treatment of underlying malignancy reduces output in malignant chylothorax. Embolization of thoracic duct via lymphangiography is increasingly used as minimally invasive alternative.

Asthma

Göğüs Hastalıkları

Asthma is characterized by wheezing, coughing and shortness of breath attacks; with proper treatment it can be kept under control.

COPD (Chronic Obstructive Pulmonary Disease)

Göğüs Hastalıkları

COPD is an irreversible lung disease characterized by shortness of breath and chronic cough; quitting smoking slows its progression.

Pneumonia

Göğüs Hastalıkları

Pneumonia presents with high fever, cough and shortness of breath; the vast majority recover with appropriate antibiotic treatment.

Tuberculosis (TB)

Göğüs Hastalıkları

Tuberculosis presents with weeks-to-months of cough, fever, and night sweats; early diagnosis and treatment lead to full recovery.

Pleural Effusion

Göğüs Hastalıkları

Pleural effusion is the accumulation of excess fluid in the pleural space, resulting from imbalances in fluid production and removal, and represents a manifestation of diverse cardiopulmonary, infectious, and malignant disorders.

Pneumothorax

Göğüs Hastalıkları

Pneumothorax is the presence of air in the pleural space resulting in partial or complete lung collapse, classified as spontaneous (primary/secondary), traumatic, or iatrogenic, with tension pneumothorax representing a life-threatening emergency.

Bronchitis (Acute and Chronic)

Göğüs Hastalıkları

Acute bronchitis is mostly viral and resolves spontaneously, while chronic bronchitis is a smoking-related component of COPD.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.